Market Research Industry Reports

Fennec Pharmaceuticals Inc (FRX) - Financial and Strategic SWOT Analysis Review

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Fennec Pharmaceuticals Inc (FRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Fennec Pharmaceuticals Inc (Fennec) formerly Adherex Technologies Inc., is a biopharmaceutical company that focuses on novel cancer treatments. It undertakes the discovery and development of new treatments for cancer focusing on tumor cells and tumor blood vessels. The company has one late stage clinical products, namely, Pedmarktm. It is a chemical reducing agent undergoing two Phase III clinical trials for the prevention of cisplatin induced hearing loss, or ototoxicity in children. The company has licensing agreements with Oregon Health & Science University for development of its drug candidates. Fennec is headquartered in Durham, North Carolina, the US.

Fennec Pharmaceuticals Inc Key Recent Developments

May 14,2018: Fennec Pharmaceuticals Announces First Quarter 2018 Financial Results
Mar 26,2018: Fennec Provides Business Update and Announces Fiscal Year Ended December 31, 2017 Financial Results
Nov 13,2017: Fennec Provides Business Update And Reports Third Quarter 2017 Results
Aug 11,2017: Fennec Provides Corporate Update and Announces Second Quarter 2017 Results
May 12,2017: Fennec Provides Corporate Update and Announces First Quarter 2017 Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Fennec Pharmaceuticals Inc - Key Facts 5
Fennec Pharmaceuticals Inc - Key Employees 6
Fennec Pharmaceuticals Inc - Key Employee Biographies 7
Fennec Pharmaceuticals Inc - Major Products and Services 8
Fennec Pharmaceuticals Inc - History 9
Fennec Pharmaceuticals Inc - Company Statement 11
Fennec Pharmaceuticals Inc - Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 Company Analysis 14
Fennec Pharmaceuticals Inc - Business Description 14
Fennec Pharmaceuticals Inc - SWOT Analysis 15
SWOT Analysis - Overview 15
Fennec Pharmaceuticals Inc - Strengths 15
Fennec Pharmaceuticals Inc - Weaknesses 16
Fennec Pharmaceuticals Inc - Opportunities 17
Fennec Pharmaceuticals Inc - Threats 18
Fennec Pharmaceuticals Inc - Key Competitors 19
Section 3 Company Financial Ratios 20
Financial Ratios - Capital Market Ratios 20
Financial Ratios - Annual Ratios 21
Performance Chart 23
Financial Performance 23
Financial Ratios - Interim Ratios 24
Financial Ratios - Ratio Charts 25
Section 4 Companys Lifesciences Financial Deals and Alliances 26
Fennec Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26
Fennec Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 27
Fennec Pharmaceuticals Inc, Recent Deals Summary 28
Section 5 Companys Recent Developments 29
Mar 26, 2018: Fennec Provides Business Update and Announces Fiscal Year Ended December 31, 2017 Financial Results 29
Nov 13, 2017: Fennec Provides Business Update And Reports Third Quarter 2017 Results 30
Aug 11, 2017: Fennec Provides Corporate Update and Announces Second Quarter 2017 Results 32
May 12, 2017: Fennec Provides Corporate Update and Announces First Quarter 2017 Results 33
Mar 30, 2017: Fennec Provides Corporate Update And Announces Fiscal Year Ended December 31, 2016 Financial Results 34
Section 6 Appendix 36
Methodology 36
Ratio Definitions 36
About GlobalData 40
Contact Us 40
Disclaimer 40

List Of Tables

List of Tables
Fennec Pharmaceuticals Inc, Key Facts 5
Fennec Pharmaceuticals Inc, Key Employees 6
Fennec Pharmaceuticals Inc, Key Employee Biographies 7
Fennec Pharmaceuticals Inc, Major Products and Services 8
Fennec Pharmaceuticals Inc, History 9
Fennec Pharmaceuticals Inc, Subsidiaries 13
Fennec Pharmaceuticals Inc, Key Competitors 19
Fennec Pharmaceuticals Inc, Ratios based on current share price 20
Fennec Pharmaceuticals Inc, Annual Ratios 21
Fennec Pharmaceuticals Inc, Annual Ratios (Cont...1) 22
Fennec Pharmaceuticals Inc, Interim Ratios 24
Fennec Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26
Fennec Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 27
Fennec Pharmaceuticals Inc, Recent Deals Summary 28
Currency Codes 36
Capital Market Ratios 36
Equity Ratios 37
Profitability Ratios 37
Cost Ratios 38
Liquidity Ratios 38
Leverage Ratios 39
Efficiency Ratios 39

List Of Figures

List of Figures
Fennec Pharmaceuticals Inc, Performance Chart (2013 - 2017) 23
Fennec Pharmaceuticals Inc, Ratio Charts 25
Fennec Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26
Fennec Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 27

Fennec Pharmaceuticals Inc (FRX) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Fennec Pharmaceuticals Inc (Fennec) formerly Adherex Technologies Inc., is a biopharmaceutical company that focuses on novel cancer treatments. It undertakes the discovery and development of new treatments for cancer focusing

USD 250View Report

Fennec Pharmaceuticals Inc (FRX) - Financial and Strategic SWOT Analysis Review

Fennec Pharmaceuticals Inc (FRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

USD 125View Report

TRACON Pharmaceuticals Inc - Mergers and Acquisitions (MandA), Partnerships and Alliances and Investment Report

TRACON Pharmaceuticals Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportThe TRACON Pharmaceuticals Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description,

USD 350View Report

Rexahn Pharmaceuticals Inc - Mergers and Acquisitions (MandA), Partnerships and Alliances and Investment Report

Rexahn Pharmaceuticals Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportThe Rexahn Pharmaceuticals Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description,

USD 350View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 125
  • Site Licence    USD 250
  • Enterprise Wide Licence    USD 375
$ 125

Reports Details

Published Date : Jun 2018
No. of Pages :40
Country :United States of America
Category :Swot Analysis
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube